Jaguar Health, Inc. (JAGX) - 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on January 6, 2023, regarding events occurring on January 5, 2023. The Company is incorporated in Delaware and its common stock trades on The NASDAQ Capital Market under the symbol "JAGX".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the market price of the Company's common stock, which closed below $0.10 per share for ten consecutive trading days prior to January 5, 2023.
Material Changes and Events
- Delisting Notice: The Company received notice from the Nasdaq Listing Qualifications Staff that its securities are subject to delisting due to failure to maintain the minimum $0.10 bid price requirement (Nasdaq Listing Rule 5810(3)(A)(iii)).
- Grace Period Status: Nasdaq previously granted a 180-calendar day grace period to regain compliance with the $1.00 bid price requirement (Nasdaq Listing Rule 5550(a)(2)), which expires on February 13, 2023.
- Appeal Action: The Company intends to request a hearing before the Nasdaq Hearings Panel to appeal the delisting decision, which will stay further delisting action pending the hearing outcome.
Outlook, Management Commentary, and Risks
- Reverse Stock Split Proposal: At a Special Meeting of Stockholders scheduled for January 20, 2023, the Company will seek approval for a reverse stock split with a ratio between 1-for-3 and 1-for-75 to regain compliance with Nasdaq listing standards.
- Uncertainty: Management notes there are no assurances that a stay of delisting will be granted or that a favorable decision will be obtained from the Hearings Panel.
- Contingency: The implementation of the reverse stock split is subject to stockholder approval and the Board's discretion.
Investor Verification Checklist
- Verify the outcome of the Nasdaq Hearings Panel appeal regarding the delisting notice.
- Confirm the specific reverse stock split ratio approved at the January 20, 2023 Special Meeting of Stockholders.
- Monitor the stock price to ensure it meets the $1.00 bid price requirement before the February 13, 2023 grace period expiration.
- Review subsequent filings for any updates on the Company's liquidity position or operational status.